只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-29 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$14.05 | US$133,779.82 | 1,032,540 | SEC |
| 2026-07-28 2026-07-29 | MEDP Medpace Holdings, Inc. | Troendle August J. Director,Officer,TenPercentOwner · President & CEO | 卖出（S） | 3,510 | US$600.01 | US$210.6万 | 638,946 | SEC |
| 2026-07-28 2026-07-29 | EDIT Editas Medicine, Inc. | Burkly Linda Officer · EVP, CHIEF SCIENTIFIC OFFICER | 卖出（S） | 4,928 | US$2.67 | US$13,157.76 | 62,369 | SEC |
| 2026-07-28 2026-07-29 | MEDP Medpace Holdings, Inc. | BURWIG SUSAN E Officer · Exec. VP, Operations | 卖出（S） | 7,500 | US$600.00 | US$450万 | 62,984 | SEC |
| 2026-07-28 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 6,622 | US$13.86 | US$91,775.62 | 865,814 | SEC |
| 2026-07-28 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 10,843 | US$13.78 | US$149,375.34 | 1,042,064 | SEC |
| 2026-07-28 2026-07-29 | TRU TransUnion | Abdelsadek Mohamed Officer · EVP, Chief Global Solutions | 卖出（S） | 23,495 | US$85.00 | US$199.71万 | 57,182 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | OrbiMed Capital GP VIII LLC Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | BEAM Beam Therapeutics Inc. | Simon Amy Officer · Chief Medical Officer | 卖出（S） | 16,667 | US$25.74 | US$429,036.91 | 85,696 | SEC |
| 2026-07-27 2026-07-29 | MEDP Medpace Holdings, Inc. | Troendle August J. Director,Officer,TenPercentOwner · President & CEO | 卖出（S） | 3,728 | US$600.85 | US$224万 | 642,456 | SEC |
| 2026-07-27 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 3,282 | US$13.28 | US$43,572.16 | 872,436 | SEC |
| 2026-07-27 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 8,205 | US$13.28 | US$108,932.86 | 1,052,907 | SEC |
| 2026-07-27 2026-07-29 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 1,000 | US$20.00 | US$20,000.00 | 51,776 | SEC |
| 2026-07-27 2026-07-28 | SOPH SOPHiA GENETICS SA | Menu Philippe Officer · Chief Medical Officer | 卖出（S） | 5,000 | US$5.66 | US$28,305.50 | 223,387 | SEC |
| 2026-07-24 2026-07-28 | GE GENERAL ELECTRIC CO | Ali Mohamed Officer · Senior Vice President | 卖出（S） | 1,769 | US$353.75 | US$625,783.75 | 21,932 | SEC |
| 2026-07-24 2026-07-28 | GE GENERAL ELECTRIC CO | Ali Mohamed Officer · Senior Vice President | 卖出（S） | 1,266 | US$353.74 | US$447,834.84 | 20,666 | SEC |
| 2026-07-24 2026-07-28 | GE GENERAL ELECTRIC CO | Ali Mohamed Officer · Senior Vice President | 卖出（S） | 2,782 | US$353.72 | US$984,049.04 | 22,945 | SEC |
| 2026-07-24 2026-07-28 | GE GENERAL ELECTRIC CO | Ali Mohamed Officer · Senior Vice President | 卖出（S） | 2,279 | US$353.64 | US$805,945.56 | 20,666 | SEC |
| 2026-07-23 2026-07-24 | INSM INSMED Inc | Lewis William Director,Officer · Chair and CEO | 卖出（S） | 4,828 | US$105.62 | US$509,933.36 | 264,930 | SEC |
| 2026-07-23 2026-07-24 | INSM INSMED Inc | Lewis William Director,Officer · Chair and CEO | 卖出（S） | 5,872 | US$106.43 | US$624,956.96 | 259,058 | SEC |
| 2026-07-22 2026-07-24 | ONC BeOne Medicines Ltd. | Lee Chan Henry Officer · SVP, General Counsel | 卖出（S） | 1,669 | US$325.00 | US$542,425.00 | 0 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$13.81 | US$68,398.51 | 875,718 | SEC |
| 2026-07-22 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$13.71 | US$130,599.75 | 1,061,112 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Chrysler Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 2,201.011 | US$877.09 | US$193.05万 | 123,267.319 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Ford Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 2,201.011 | US$877.09 | US$193.05万 | 123,267.319 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW GM RETIREES MEDICAL BENEFITS PLAN TenPercentOwner | 买入（P） | 2,201.011 | US$877.09 | US$193.05万 | 123,267.319 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Chrysler Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 3,431.32 | US$877.09 | US$300.96万 | 192,170.6 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Ford Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 3,431.32 | US$877.09 | US$300.96万 | 192,170.6 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW GM RETIREES MEDICAL BENEFITS PLAN TenPercentOwner | 买入（P） | 3,431.32 | US$877.09 | US$300.96万 | 192,170.6 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Chrysler Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 5,654.906 | US$877.09 | US$495.99万 | 316,702.201 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Ford Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 5,654.906 | US$877.09 | US$495.99万 | 316,702.201 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW GM RETIREES MEDICAL BENEFITS PLAN TenPercentOwner | 买入（P） | 5,654.906 | US$877.09 | US$495.99万 | 316,702.201 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 15,379 | US$316.26 | US$486.38万 | 46,018 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 20,029 | US$316.91 | US$634.73万 | 25,989 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 7,842 | US$318.41 | US$249.7万 | 18,147 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 15,807 | US$319.29 | US$504.7万 | 2,340 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 2,340 | US$320.06 | US$748,936.42 | 0 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$14.33 | US$70,970.58 | 880,670 | SEC |
| 2026-07-21 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$14.33 | US$136,475.11 | 1,070,636 | SEC |
| 2026-07-21 2026-07-21 | MIN ABERDEEN INTERMEDIATE INCOME FUND | Reit Todd Director | 买入（P） | 4,400 | US$2.49 | US$10,956.00 | 4,400 | SEC |
| 2026-07-20 2026-07-24 | GDTC CytoMed Therapeutics Ltd | Choo Chee Kong Director,TenPercentOwner | 买入（P） | 100,000 | US$1.50 | US$150,000.00 | 630,324 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 5,146 | US$310.08 | US$159.57万 | 9,180 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 6,273 | US$310.75 | US$194.93万 | 2,907 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 2,907 | US$311.80 | US$906,388.65 | 0 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 15,499 | US$312.29 | US$484.01万 | 18,491 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 14,326 | US$312.96 | US$448.34万 | 4,165 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,850 | US$313.91 | US$580,731.65 | 2,315 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,512 | US$315.26 | US$476,677.66 | 803 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 523 | US$316.14 | US$165,339.28 | 280 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 280 | US$318.30 | US$89,124.00 | 0 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$13.87 | US$68,684.74 | 885,622 | SEC |
| 2026-07-20 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$13.82 | US$131,657.87 | 1,080,160 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 231 | US$50.05 | US$11,562.52 | 29,769 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 459 | US$51.55 | US$23,659.89 | 29,310 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 2,063 | US$52.39 | US$108,084.90 | 27,247 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 2,184 | US$53.42 | US$116,669.06 | 25,063 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 63 | US$53.92 | US$3,397.01 | 25,000 | SEC |
| 2026-07-17 2026-07-20 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 416 | US$26.53 | US$11,036.48 | 51,384 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,440 | US$305.20 | US$439,485.84 | 63,188 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 597 | US$306.96 | US$183,257.63 | 62,591 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 680 | US$309.05 | US$210,156.79 | 61,911 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 4,833 | US$310.37 | US$150万 | 57,078 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 5,543 | US$311.42 | US$172.62万 | 51,535 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 35,829 | US$312.17 | US$1118.49万 | 15,706 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 14,915 | US$313.19 | US$467.12万 | 791 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 740 | US$314.32 | US$232,596.65 | 51 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 51 | US$315.06 | US$16,068.18 | 0 | SEC |
| 2026-07-17 2026-07-17 | MAX MediaAlpha, Inc. | Yeh Kuanling Amy Officer · Chief Technology Officer | 卖出（S） | 3,000 | US$13.95 | US$41,850.00 | 553,985 | SEC |
| 2026-07-17 2026-07-17 | MAX MediaAlpha, Inc. | Yi Steven Director,Officer · See Remarks | 卖出（S） | 12,333 | US$14.20 | US$175,095.30 | 2,459,690 | SEC |
| 2026-07-17 2026-07-17 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 4,839 | US$4.53 | US$21,920.67 | 2,814,640 | SEC |
| 2026-07-17 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 3,656 | US$37.90 | US$138,562.40 | 298,901 | SEC |
| 2026-07-16 2026-07-20 | INCY INCYTE CORP | Issa Mohamed Khairie Officer · EVP, Head of U.S. Commercial | 卖出（S） | 1,093 | US$115.01 | US$125,705.93 | 63,940 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 233 | US$311.98 | US$72,691.34 | 166,364 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 4,881 | US$314.08 | US$153.3万 | 161,483 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 9,516 | US$314.73 | US$299.5万 | 151,967 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 19,752 | US$316.00 | US$624.16万 | 132,215 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 32,224 | US$316.82 | US$1020.91万 | 99,991 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 42,798 | US$317.79 | US$1360.07万 | 57,193 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 6,402 | US$318.55 | US$203.94万 | 50,791 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 15,097 | US$319.99 | US$483.09万 | 35,694 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 20,505 | US$321.00 | US$658.21万 | 15,189 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 13,109 | US$321.61 | US$421.6万 | 2,080 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,560 | US$322.71 | US$503,423.86 | 520 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 520 | US$323.59 | US$168,264.62 | 0 | SEC |
| 2026-07-16 2026-07-17 | MAX MediaAlpha, Inc. | Yeh Kuanling Amy Officer · Chief Technology Officer | 卖出（S） | 10,000 | US$14.51 | US$145,080.00 | 556,985 | SEC |
| 2026-07-16 2026-07-17 | MAX MediaAlpha, Inc. | Yi Steven Director,Officer · See Remarks | 卖出（S） | 82,457 | US$14.39 | US$118.66万 | 2,472,023 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 9,163 | US$36.46 | US$334,082.98 | 308,441 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 5,865 | US$37.26 | US$218,529.90 | 302,576 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 19 | US$37.96 | US$721.24 | 302,557 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 6,067 | US$310.02 | US$188.09万 | 110,490 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 41,336 | US$310.92 | US$1285.23万 | 69,154 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 12,857 | US$311.71 | US$400.77万 | 56,297 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 48,657 | US$312.86 | US$1522.27万 | 7,640 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 7,640 | US$313.58 | US$239.57万 | 0 | SEC |
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 11,216 | US$22.01 | US$246,869.77 | 560,721 | SEC |
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 784 | US$22.63 | US$17,744.51 | 559,937 | SEC |
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 3,000 | US$24.00 | US$71,994.90 | 556,937 | SEC |
| 2026-07-15 2026-07-17 | HTFL Heartflow, Inc. | Rogers Campbell Officer · Chief Medical Officer | 卖出（S） | 9,219 | US$25.72 | US$237,112.68 | 88,731 | SEC |
| 2026-07-15 2026-07-17 | INM InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC TenPercentOwner | 买入（P） | 1,000 | US$1.56 | US$1,555.00 | 801,000 | SEC |
| 2026-07-15 2026-07-17 | INM InMed Pharmaceuticals Inc. | Schneeberger Daniel TenPercentOwner | 买入（P） | 1,000 | US$1.56 | US$1,555.00 | 801,000 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 7,155 | US$36.16 | US$258,724.80 | 338,904 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 7,845 | US$37.04 | US$290,578.80 | 331,059 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 4,465 | US$36.00 | US$160,740.00 | 326,594 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 8,972 | US$36.99 | US$331,874.28 | 317,622 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 18 | US$37.54 | US$675.72 | 317,604 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | VANI Vivani Medical, Inc. | Williams Gregg Director,TenPercentOwner | 买入（P） | 793,650 | US$1.26 | US$999,999.00 | 36,912,736 | SEC |
| 2026-07-15 2026-07-16 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 13,119 | US$4.67 | US$61,265.73 | 2,819,479 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 400 | US$84.37 | US$33,746.00 | 39,318 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 2,497 | US$85.86 | US$214,385.43 | 36,821 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 3,803 | US$86.68 | US$329,630.35 | 33,018 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 300 | US$87.25 | US$26,175.99 | 32,718 | SEC |
| 2026-07-15 2026-07-15 | MAX MediaAlpha, Inc. | Cramer Keith Officer · Chief Revenue Officer | 卖出（S） | 13,000 | US$14.19 | US$184,494.70 | 267,528 | SEC |
| 2026-07-15 2026-07-15 | MAX MediaAlpha, Inc. | Yi Steven Director,Officer · See Remarks | 卖出（S） | 114,292 | US$14.17 | US$161.91万 | 2,554,480 | SEC |
| 2026-07-15 2026-07-15 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$14.03 | US$69,456.26 | 890,574 | SEC |
| 2026-07-15 2026-07-15 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$14.14 | US$134,675.07 | 1,089,684 | SEC |
| 2026-07-15 2026-07-15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 6,349 | US$26.61 | US$168,954.51 | 51,384 | SEC |
| 2026-07-14 2026-07-24 | GDTC CytoMed Therapeutics Ltd | Choo Chee Kong Director,TenPercentOwner | 买入（P） | 100,000 | US$1.50 | US$150,000.00 | 530,324 | SEC |
| 2026-07-14 2026-07-16 | GALT GALECTIN THERAPEUTICS INC | Jamil Khurram Officer · Chief Medical Officer | 卖出（S） | 16,250 | US$5.13 | US$83,284.50 | 0 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | TOI Oncology Institute, Inc. | Podnos Yale Officer · Chief Medical Officer | 卖出（S） | 17,974 | US$6.43 | US$115,554.85 | 259,527 | SEC |
| 2026-07-14 2026-07-16 | TOI Oncology Institute, Inc. | Podnos Yale Officer · Chief Medical Officer | 卖出（S） | 5,478 | US$6.35 | US$34,785.30 | 259,527 | SEC |
| 2026-07-14 2026-07-15 | QLYS QUALYS, INC. | Thakar Sumedh S Director,Officer · CEO & PRESIDENT | 卖出（S） | 100 | US$149.30 | US$14,930.00 | 196,586 | SEC |
| 2026-07-14 2026-07-15 | QLYS QUALYS, INC. | Thakar Sumedh S Director,Officer · CEO & PRESIDENT | 卖出（S） | 100 | US$151.53 | US$15,153.00 | 196,486 | SEC |
| 2026-07-14 2026-07-15 | QLYS QUALYS, INC. | Thakar Sumedh S Director,Officer · CEO & PRESIDENT | 卖出（S） | 100 | US$155.30 | US$15,530.00 | 196,386 | SEC |
| 2026-07-14 2026-07-15 | QLYS QUALYS, INC. | Thakar Sumedh S Director,Officer · CEO & PRESIDENT | 卖出（S） | 200 | US$157.75 | US$31,549.00 | 196,186 | SEC |
| 2026-07-14 2026-07-15 | QLYS QUALYS, INC. | Thakar Sumedh S Director,Officer · CEO & PRESIDENT | 卖出（S） | 730 | US$160.81 | US$117,394.80 | 195,456 | SEC |
| 2026-07-14 2026-07-15 | QLYS QUALYS, INC. | Thakar Sumedh S Director,Officer · CEO & PRESIDENT | 卖出（S） | 1,570 | US$161.69 | US$253,860.99 | 193,886 | SEC |
| 2026-07-14 2026-07-15 | QLYS QUALYS, INC. | Thakar Sumedh S Director,Officer · CEO & PRESIDENT | 卖出（S） | 200 | US$162.40 | US$32,480.00 | 193,686 | SEC |
| 2026-07-14 2026-07-15 | QLYS QUALYS, INC. | Thakar Sumedh S Director,Officer · CEO & PRESIDENT | 卖出（S） | 200 | US$163.57 | US$32,713.00 | 193,486 | SEC |
| 2026-07-14 2026-07-15 | MAX MediaAlpha, Inc. | Yi Steven Director,Officer · See Remarks | 卖出（S） | 37,701 | US$14.06 | US$530,004.43 | 2,668,772 | SEC |
| 2026-07-14 2026-07-15 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$13.85 | US$68,599.07 | 895,526 | SEC |
| 2026-07-14 2026-07-15 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$13.90 | US$132,410.27 | 1,099,208 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 4,139 | US$303.07 | US$125.44万 | 8,122 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 8,122 | US$303.93 | US$246.85万 | 0 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 39,090 | US$305.02 | US$1192.33万 | 94,510 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 45,895 | US$306.21 | US$1405.36万 | 48,615 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 40,781 | US$306.93 | US$1251.71万 | 7,834 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 7,834 | US$307.57 | US$240.95万 | 0 | SEC |
| 2026-07-13 2026-07-15 | MAX MediaAlpha, Inc. | Yi Steven Director,Officer · See Remarks | 卖出（S） | 9,496 | US$14.05 | US$133,396.96 | 2,706,473 | SEC |
| 2026-07-13 2026-07-15 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 6,622 | US$13.81 | US$91,427.31 | 900,478 | SEC |
| 2026-07-13 2026-07-15 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 10,843 | US$13.76 | US$149,208.35 | 1,108,732 | SEC |
| 2026-07-13 2026-07-15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 14,058 | US$27.58 | US$387,716.83 | 57,733 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 798 | US$301.94 | US$240,945.25 | 47,722 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 4,584 | US$302.79 | US$138.8万 | 43,138 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| MEDS | 11,509 | 0 | 14,748.5286 | 78.03% | Q, N |
| GMED | 261,060.101 | 537 | 349,571.7399 | 74.68% | B, Q, N |
| TMED | 9,317 | 0 | 12,742.3609 | 73.12% | Q, N |
| BMED | 41.1613 | 0 | 58.3439 | 70.55% | Q, N |
| MED | 28,649.0902 | 0 | 45,804.2258 | 62.55% | B, Q, N |
| MMED | 127,064.2316 | 0 | 221,794.5327 | 57.29% | B, Q, N |
| MEDP | 58,879.4137 | 840 | 103,812.434 | 56.72% | B, Q, N |
| FMED | 1,265 | 0 | 3,982.5529 | 31.76% | Q |
| MEDI | 248 | 0 | 1,327.9819 | 18.67% | Q |